High materiality7/10
Acadia Pharmaceuticals price target raised to $41 from $38 at Needham
Why it may matterVerify against the original reporting
bullish
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Needham raises ACAD PT to $41; current price $29.41.
- PT $41; price $29.41; Needham
Key facts
- 01
Target: $41
- 02
Posted price: $29.41
- 03
Analyst firm: Needham
- 04
Analyst: Ami Fadia
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.